MD1587B2 - Compozitie retinoida si utilizarea ei in calitate de remediu terapeutic pentru aplicare topica pe piele - Google Patents

Compozitie retinoida si utilizarea ei in calitate de remediu terapeutic pentru aplicare topica pe piele

Info

Publication number
MD1587B2
MD1587B2 MD95-0443A MD950443A MD1587B2 MD 1587 B2 MD1587 B2 MD 1587B2 MD 950443 A MD950443 A MD 950443A MD 1587 B2 MD1587 B2 MD 1587B2
Authority
MD
Moldova
Prior art keywords
utilization
composition
retinoid
cutaneous application
topical
Prior art date
Application number
MD95-0443A
Other languages
English (en)
Other versions
MD950443A (ro
MD1587C2 (ro
Inventor
Vringer Tom De
Harrewiin Antoon Van
Aart Muehlenbruch
Original Assignee
Yamanouchi Europ Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8213946&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MD1587(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Yamanouchi Europ Bv filed Critical Yamanouchi Europ Bv
Publication of MD950443A publication Critical patent/MD950443A/ro
Publication of MD1587B2 publication Critical patent/MD1587B2/ro
Publication of MD1587C2 publication Critical patent/MD1587C2/ro

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203—Retinoic acids ; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/39—Derivatives containing from 2 to 10 oxyalkylene groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/86—Polyethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/90—Block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
MD95-0443A 1993-07-01 1994-07-01 Eteri de 2,6-dihidroxipiridină, procedeu de preparare a lor, compoziţie erbicidă şi metodă de combatere a creşterii plantelor indezirabile MD1587C2 (ro)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP93201931 1993-07-01
PCT/NL1994/000151 WO1995001160A1 (en) 1993-07-01 1994-07-01 Stable topical retinoid compositions

Publications (3)

Publication Number Publication Date
MD950443A MD950443A (ro) 1997-09-30
MD1587B2 true MD1587B2 (ro) 2001-01-31
MD1587C2 MD1587C2 (ro) 2001-06-30

Family

ID=8213946

Family Applications (1)

Application Number Title Priority Date Filing Date
MD95-0443A MD1587C2 (ro) 1993-07-01 1994-07-01 Eteri de 2,6-dihidroxipiridină, procedeu de preparare a lor, compoziţie erbicidă şi metodă de combatere a creşterii plantelor indezirabile

Country Status (23)

Country Link
US (1) US5690923A (ro)
EP (1) EP0706370B2 (ro)
JP (2) JP3947215B2 (ro)
AT (1) ATE202694T1 (ro)
AU (1) AU678039B2 (ro)
BG (1) BG61713B1 (ro)
CA (1) CA2166062C (ro)
CZ (1) CZ285679B6 (ro)
DE (1) DE69427639T3 (ro)
DK (1) DK0706370T4 (ro)
ES (1) ES2160631T5 (ro)
FI (1) FI115607B (ro)
GR (1) GR3036761T3 (ro)
HU (1) HU217869B (ro)
MD (1) MD1587C2 (ro)
NO (1) NO311066B1 (ro)
PT (1) PT706370E (ro)
RO (1) RO115109B1 (ro)
RU (1) RU2134101C1 (ro)
SI (1) SI0706370T2 (ro)
SK (1) SK279919B6 (ro)
UA (1) UA41937C2 (ro)
WO (1) WO1995001160A1 (ro)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK279919B6 (sk) * 1993-07-01 1999-05-07 Yamanouchi Europe B.V. Farmaceutický a kozmetický prostriedok na miestne
EP0974364A4 (en) * 1996-10-25 2000-12-20 Yoshitomi Pharmaceutical METHOD FOR PREVENTING THE PREPARATION OF MEDICINAL PRODUCTS
DE19903729A1 (de) * 1999-01-30 2000-08-03 Beiersdorf Ag Verwendung von oberflächenaktiven Citronensäureestern zur Stabilisierung von Retinoiden, synergistische Gemische aus Retinoiden und oberflächenaktiven Substanzen sowie kosmetische und dermatologische Zubereitungen mit einem Gehalt an solchen Gemischen
CA2382214A1 (en) * 1999-08-20 2001-03-01 Unilever Plc Skin cosmetic compositions for reducing skin irritation from weak carboxylic acids
DE10025756C2 (de) * 2000-05-25 2003-02-20 Cognis Deutschland Gmbh Lösungsvermittler
US6387383B1 (en) 2000-08-03 2002-05-14 Dow Pharmaceutical Sciences Topical low-viscosity gel composition
US20060189552A1 (en) * 2000-12-12 2006-08-24 Mohan Vishnupad Dispenser for dispensing three or more actives
US7060732B2 (en) * 2000-12-12 2006-06-13 Imaginative Research Associates, Inc. Antibiotic/benzoyl peroxide dispenser
US20110142922A1 (en) * 2002-04-30 2011-06-16 Ferndale Ip, Inc. Stabilized composition and method for dermatological treatment
US20030215493A1 (en) * 2002-04-30 2003-11-20 Patel Pravin M. Composition and method for dermatological treatment
US7939489B2 (en) * 2002-12-23 2011-05-10 Avon Products, Inc. Oil absorbent topical compositions and methods for using same
MXPA05007722A (es) 2003-01-24 2006-01-31 Connetics Australia Pty Ltd Espuma de fosfato de clindamicina.
US7662855B2 (en) * 2004-05-11 2010-02-16 Imaginative Research Associates, Inc. Retinoid solutions and formulations made therefrom
US20060014834A1 (en) * 2004-05-11 2006-01-19 Mohan Vishnupad Retinoid solutions and formulations made therefrom
JP2008519764A (ja) 2004-11-09 2008-06-12 イマジナティブ リサーチ アソシエィツ インコーポレーテッド レチノイド溶液及びそれからつくった調合物
AU2005306397A1 (en) * 2004-11-19 2006-05-26 Aventis Pharmaceuticals Inc. Antibiotic compounds, compositions and medical uses
US20060222712A1 (en) * 2005-02-17 2006-10-05 Connetics Corporation Acne gel
AR054805A1 (es) * 2005-06-29 2007-07-18 Stiefel Laboratories Composiciones topicas para el tratamiento de la piel
US9107844B2 (en) * 2006-02-03 2015-08-18 Stiefel Laboratories Inc. Topical skin treating compositions
RU2419429C2 (ru) * 2006-03-08 2011-05-27 Нихон Нохияку Ко.,Лтд. Фармацевтическая композиция для наружного применения
US8349882B2 (en) * 2006-03-08 2013-01-08 Nihon Nohyaku Co., Ltd. Pharmaceutical composition for external use
PL2206494T3 (pl) 2006-03-31 2016-06-30 Stiefel Res Australia Pty Ltd Spienialny żel zawiesinowy
US20080287373A1 (en) * 2007-05-17 2008-11-20 Popp Karl F Topical skin treating kits
CN101790364B (zh) * 2007-06-21 2013-07-24 陶氏环球技术公司 用于个人护理组合物中的疏水组分的稳定剂
JP5345937B2 (ja) * 2007-09-05 2013-11-20 株式会社ポーラファルマ 抗真菌組成物
CN101808637B (zh) * 2007-09-05 2013-07-24 宝丽制药股份有限公司 医药组合物
JP5453093B2 (ja) * 2007-09-05 2014-03-26 株式会社ポーラファルマ 抗真菌医薬組成物
JP2011500687A (ja) * 2007-10-18 2011-01-06 メディシス・ファーマシューティカル・コーポレーション 水性レチノイドおよび過酸化ベンゾイルゲル
FR2939683B1 (fr) * 2008-12-17 2012-04-20 Oreal Composition cosmetique comprenant un polyester sulfonique ramifie et un tensioactif particulier et utilisations en coiffage
EP2416758B8 (en) * 2009-04-09 2017-10-18 Pola Pharma Inc. Antimycotic pharmaceutical composition
US10130610B2 (en) 2009-04-09 2018-11-20 Pola Pharma Inc. Antimycotic pharmaceutical composition
CN102481286B (zh) 2009-08-25 2014-02-26 宝丽制药股份有限公司 抗真菌药物组合物
US11071878B2 (en) * 2009-12-31 2021-07-27 Sol-Gel Technologies Ltd. Core stabilized microcapsules, method of their preparation and uses thereof
JP5865624B2 (ja) * 2011-08-01 2016-02-17 昭和電工株式会社 皮膚外用剤およびその製造方法
JP5865623B2 (ja) * 2011-08-01 2016-02-17 昭和電工株式会社 皮膚外用剤およびその製造方法
FR2991175B1 (fr) * 2012-06-01 2014-12-19 Galderma Res & Dev Compositions pharmaceutiques topiques de type emulsion h/e contenant un retinoide
MD4479C1 (ro) * 2015-02-12 2017-12-31 Валериу НИКУШОР Compoziţie de erbicide şi procedeu de combatere a buruienilor şi ierburilor în culturile de sfeclă de zahăr cu utilizarea acesteia

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4532133A (en) * 1983-05-24 1985-07-30 Basf Wyandotte Corporation Low temperature stable, emulsifiable vitamin A concentrates
FR2591105B1 (fr) * 1985-12-11 1989-03-24 Moet Hennessy Rech Composition pharmaceutique, notamment dermatologique, ou cosmetique, a base de phases lamellaires lipidiques hydratees ou de liposomes contenant un retinoide ou un analogue structural dudit retinoide tel qu'un carotenoide.
GB8821129D0 (en) † 1988-09-09 1988-10-12 Unilever Plc Cosmetic composition
MY105521A (en) * 1989-04-17 1994-10-31 Healthpoint Ltd Moisturizing vehicle for topical application of vitamin a acid.
US5721275A (en) * 1989-06-07 1998-02-24 Bazzano; Gail S. Slow release vehicles for minimizing skin irritancy of topical compositions
JP2827295B2 (ja) * 1989-07-04 1998-11-25 大正製薬株式会社 ビタミンａ類含有点眼剤
FI903483A0 (fi) * 1989-07-13 1990-07-10 Bristol Myers Squibb Co Tretinoin innehaollande stabila emulsionskraemformulationer.
US5043356A (en) * 1990-01-19 1991-08-27 Fulton Jr James E Composition and method for rejuvenating skin using vitamin A propionate
JP3031990B2 (ja) * 1990-10-19 2000-04-10 同仁医薬化工株式会社 消炎鎮痛クリーム剤組成物
SK279919B6 (sk) * 1993-07-01 1999-05-07 Yamanouchi Europe B.V. Farmaceutický a kozmetický prostriedok na miestne

Also Published As

Publication number Publication date
AU7391394A (en) 1995-01-24
MD950443A (ro) 1997-09-30
SI0706370T1 (en) 2001-12-31
BG100267A (bg) 1996-07-31
NO311066B1 (no) 2001-10-08
CA2166062A1 (en) 1995-01-12
JP2006328089A (ja) 2006-12-07
DK0706370T4 (da) 2005-04-18
DE69427639D1 (de) 2001-08-09
NO955193L (no) 1996-02-08
RU2134101C1 (ru) 1999-08-10
PT706370E (pt) 2001-11-30
US5690923A (en) 1997-11-25
JP3947215B2 (ja) 2007-07-18
ATE202694T1 (de) 2001-07-15
CZ348395A3 (en) 1996-04-17
DE69427639T3 (de) 2005-08-04
UA41937C2 (uk) 2001-10-15
HU9503721D0 (en) 1996-02-28
MD1587C2 (ro) 2001-06-30
WO1995001160A1 (en) 1995-01-12
BG61713B1 (bg) 1998-04-30
DK0706370T3 (da) 2001-09-17
JPH08512049A (ja) 1996-12-17
EP0706370A1 (en) 1996-04-17
FI115607B (fi) 2005-06-15
SK159795A3 (en) 1997-03-05
EP0706370B1 (en) 2001-07-04
SI0706370T2 (en) 2005-06-30
AU678039B2 (en) 1997-05-15
FI956204A0 (fi) 1995-12-22
FI956204A (fi) 1995-12-22
HU217869B (hu) 2000-04-28
DE69427639T2 (de) 2001-10-18
ES2160631T3 (es) 2001-11-16
GR3036761T3 (en) 2001-12-31
SK279919B6 (sk) 1999-05-07
ES2160631T5 (es) 2005-07-16
CA2166062C (en) 2008-09-16
RO115109B1 (ro) 1999-11-30
NO955193D0 (no) 1995-12-20
HUT74072A (en) 1996-10-28
EP0706370B2 (en) 2005-01-26
CZ285679B6 (cs) 1999-10-13

Similar Documents

Publication Publication Date Title
MD1587B2 (ro) Compozitie retinoida si utilizarea ei in calitate de remediu terapeutic pentru aplicare topica pe piele
BR0104872A (pt) Uso de ácido lipóico e composição dermatológica
CA2144509A1 (en) Skin-conditioning composition, its application and manufacture
SE9402558D0 (sv) Ny användning av azatricykloderivat och farmaceutiska kompositioner innehållande desamma
DE69523744D1 (de) Deodorant- und antitranspirantpräparate
NO171095C (no) Fremgangsmaate for fremstilling av en topisk antibakteriell salve
IL109526A0 (en) Benzofuranyl- and thiophenyl-alkanecarboxylic acid derivatives, their preparation and pharmaceutical compositions containing them
KR950007850A (ko) 항균물질 및 항궤양물질 포함 제제
MY101536A (en) Anti-inflammatory and analgesic tape for external use
AU7263591A (en) Benzisothiazolinone-1-dioxide derivatives as elastase inhibitors
BR9913589A (pt) Composição, e, processo cosmético para reduzir ardência ou irritação induzidas pela aplicação tópica de uma composição
ES8700049A1 (es) Un procedimiento para la preparacion de una composicion topica para reducir la secrecion de sebo
SE7600436L (sv) Tretinoininnehallande gel for behandling av acne
MXPA03010861A (es) COMPOSICION TOPICA QUE COMPRENDE UN AGENTE DE UNION COSMeTICO TRANSESTRUCTURADO Y ACTIVADO.
GB1335783A (en) Anti-seborrhoeic compositions
RU94038042A (ru) Производные гексагидроазепинов, фармацевтическая композиция на их основе и антипсихотропный агент
ES8500712A1 (es) Procedimiento de obtencion de una composicion para controlar o erradicar infestaciones de ectoparasitos y endoparasitos en animales.
AU629445B2 (en) Improvements in or relating to topical compositions containing 1 alpha 25-dihydroxycholecalciferol
ES8404679A1 (es) Procedimiento para preparar un derivado de nitroimidazol.
KR940018351A (ko) 노나테트라에노산 유도체
DE3580277D1 (de) Chemische verbindung mit antimykotischer, vernarbungsfoerdernder und entzuendungshemmender wirkung.
ES8601690A1 (es) Un procedimiento para la obtencion de preparados del bifanazol con elevada liberacion del producto actuvo
ES8704951A1 (es) Un procedimiento para la preparacion de nuevos derivados penem.
AU1201900A (en) Topical vitamin composition
WO1999024042A3 (en) Stable antiandrogenic gel composition

Legal Events

Date Code Title Description
PD99 Pending application
TC4A Change of name of proprietor (patent for invention)

Owner name: ASTELLAS PHARMA EUROPE B.V., NL

Free format text: FORMER OWNER: YAMANOUCHI EUROPE B.V., NL

KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MK4A Patent for invention expired